Default company panoramic image
9c7b5ef2 c7ab 4579 8f73 28e5b72dcaf1

Lubax, Inc.

A mobile app to identify skin diseases. Take a photo of a skin lesion and Lubax returns best-matching images from a proprietary database of diagnosed lesions.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Los Angeles, CA, US
  • Currency USD
  • Founded January 2012
  • Employees 5
  • Website

Company Summary

Lubax is a mobile app that identifies skin diseases instantaneously. Take a photo of a skin lesion and Lubax returns best-matching images from database of diagnosed lesions. First patented system to allow physicians to ID images of skin disease. Trial for melanomas (>1.0cm) shows >90% accuracy, with many other skin conditions to follow. After FDA approval we will market to physicians. Revenue model includes both subscriptions and pharma ads.


  • Default avatar
    Raymond H. Chen

    A Harvard- and Stanford-trained Cardiac Surgeon who also received a D.Phil from Oxford University as a Churchill Scholar on the application of new technology in clinical medicine. During his Post-Doctorate Fellowship at Harvard Medical School, he developed new diagnostic tests for organ rejection. Funded by the NIH, Howard Hughes Institute, and others, he has received over ten research awards and multiple patents for medical implants.

  • Default avatar
    Magnus Snorrason

    A Harvard- and Boston University-trained Scientist, formerly Principal Scientist for Computer Vision at Charles River Analytics. He was responsible for multiple Pentagon-sponsored video analysis programs, as well as for image analyses used by a NASA rover currently on Mars. He is an experienced team leader in the management and development of computer vision projects.

  • Default avatar
    Donna-Bea Tillman, PhD
    FDA Consultant

    She was Director of the Office of Device Evaluation (ODE) at the FDA, where she was responsible for the review and approval of all medical devices in the U.S. She personally wrote the FDA regulations for medical software, and was recruited by Microsoft to head the Regulatory Affairs Office. She is taking the lead in guiding our software through the FDA approval process.

  • Default avatar
    Hensin Tsao, MD, PhD
    Clinical Advisor

    Associate Professor of Dermatology at Harvard Medical School, Director of the Melanoma and Pigmented Lesion Center at the Massachusetts General Hospital, Boston, MA. He provides continuous feedback and evaluation of the project and will co-lead the clinical efforts to introduce the Lubax device to Dermatologists.

  • Default avatar
    Brad Tsai

    Former co-founder HiSoft USA (Envisage Solutions), IPO Nasdaq 2010, 20 years of experience in technology, consulting and business development.


  • Default avatar
    McDermott Will & Emery LLP
    Default avatar
    Jenkins Bowler LLP

Previous Investors

  • Default avatar
    Raymond Chen and family: $1,300,000